CBMG
Cellular Biomedicine Group, Inc.
CBMG
CBMG
Delisted
CBMG was delisted on the 19th of February, 2021.
34 hedge funds and large institutions have $27.6M invested in Cellular Biomedicine Group, Inc. in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
36% more funds holding
Funds holding: 25 → 34 (+9)
Holders
34
Holding in Top 10
–
Calls
$21K
Puts
$3K
Top Buyers
| 1 | +$9.76M | |
| 2 | +$2.55M | |
| 3 | +$856K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$672K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$663K |
Top Sellers
| 1 | -$1.84M | |
| 2 | -$927K | |
| 3 | -$755K | |
| 4 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$487K |
| 5 |
SEI Investments
Oaks,
Pennsylvania
|
-$67K |